SAINT PAUL, Minn.--(BUSINESS WIRE)--Angeion Corporation (NASDAQ:ANGN) today reported results for its third quarter ended July 31, 2007. “As anticipated, sales to our core markets showed notable year-over-year revenue growth. This growth was strong enough to offset the expected revenue-reduction from our large clinical research customer, as it enters the next phase of its clinical trials which does not require additional cardiorespiratory diagnostic systems,” Rodney A. Young, President and Chief Executive Officer commented. “Our third quarter performance in the hospital, physician office, clinic and health & fitness club markets reflects the continuing strength of our sales and marketing teams and our product technologies.”
